There are 113 ASX 200 boards which have reached 30% women on their boards but two firms remain without any female directors and only 10 have a female chief executive....

As Moderna becomes the second firm to announce a successful COVID-19 vaccine trial, its shares have risen by more than 400% since the start of the year. ...

The stock’s price rose by 12% on Tuesday but is unlikely to have a ‘meaningful impact’ on its value in the long term but will help it reach a broader reach of consumers, ...

The value of deferred loans has fallen from $250 billion at its peak in June to $86 billion....

Former cryptocurrency promoter, John Bigatton, has been charged with operating an unregistered managed investment scheme with the investigation aided by the FBI. ...

Buy now, pay later providers have responded to a regulatory report from the Australian Securities and Investments Commission which warned of consumers forgoing essentials...

A year of testing failed to prevent the Australian Securities Exchange being frozen for several hours after it launched a new ASX Trade trading platform....

Super fund AustralianSuper has risen to be recognised as one of the top 50 largest asset owners in the world, with US$129,095 in assets. ...

The social distancing measures enforced by COVID-19 contributed to fewer deaths as Australia avoided the usual ‘hump’ of deaths in June and July. ...

There could be ‘losers’ from the creation of a COVID-19 vaccine as a return to normal life could be negative for certain stocks which have seen their share prices rise st...